ArticleJournal of prevention (2022)2022
Cost-Benefit Analysis of Human Papillomavirus Vaccine in Iran.
Nasrin Sargazi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ArticleJournal of prevention (2022)2022
Nasrin Sargazi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.